Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - ROCKLAGE SCOTT M

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for ROCKLAGE SCOTT M

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-10-29
Purchase
2019-10-31
6:03 pm
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
454,545 $11 $4,999,995 3,214,721
(Indirect)
View
2019-06-27
Sale
2019-07-01
8:01 pm
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
810,000 $21.87 $17,714,700 3,888,216
(Indirect)
View
2019-06-21
Sale
2019-06-25
7:03 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
Former 10% holder
250,000 $22.2 $5,550,000 2,267,797
(Indirect)
View
2019-06-07
Sale
2019-06-11
09:58 am
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
190,000 $19.65 $3,733,500 4,326,910
(Indirect)
View
2019-05-28
Purchase
2019-05-28
8:40 pm
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
750,000 $10 $7,500,000 2,844,545
(Indirect)
View
2019-05-16
Sale
2019-05-20
4:26 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
615,000 $21.47 $13,204,050 5,314,484
(Indirect)
View
2019-03-28
Sale
2019-04-01
5:31 pm
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
361,129 $14.16 $5,112,684 4,512,136
(Indirect)
View
2019-03-18
Sale
2019-03-20
4:48 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
154,839 $24.25 $3,754,954 2,507,797
(Indirect)
View
2019-01-22
Sale
2019-01-24
7:01 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
262,153 $21.88 $5,734,597 3,107,642
(Indirect)
View
2018-12-10
Sale
2018-12-12
8:10 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
15,575 $26.01 $405,029 5,904,884
(Indirect)
View
2018-11-23
Sale
2018-11-27
6:08 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
29,682 $20.04 $594,709 5,919,836
(Indirect)
View
2018-11-16
Sale
2018-11-20
5:05 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
525,900 $20.2 $10,623,180 5,948,331
(Indirect)
View
2018-07-20
Purchase
2018-07-20
7:02 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
115,000 $17 $1,955,000 3,359,309
(Indirect)
View
2017-11-21
Purchase
2017-11-21
7:16 pm
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
654,762 $14 $9,166,668 3,123,302
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-10-29
Conversion
2019-10-31
6:03 pm
N/A
N/A
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
3,214,721 $0 3,214,721
(Indirect)
View
2019-10-29
Conversion
2019-10-31
6:03 pm
N/A
N/A
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
3,146,551 $0 3,214,721
(Indirect)
View
2019-10-29
Conversion
2019-10-31
6:03 pm
N/A
N/A
Cabaletta Bio Inc. CABA 5AM Ventures V L.P.
5AM Partners V LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
1,675,532 $0 3,214,721
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
1,913,910 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
79,746 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
492,475 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
20,519 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
1,913,910 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
79,746 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
492,475 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
20,519 $0 2,418,548
(Indirect)
View
2019-09-16
Other
2019-09-18
9:32 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
438,694 $0 3,098,567
(Indirect)
View
2019-09-16
Other
2019-09-18
9:32 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
11,306 $0 3,098,567
(Indirect)
View
2019-09-16
Other
2019-09-18
9:32 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
85,396 $0 3,098,567
(Indirect)
View
2019-09-16
Other
2019-09-18
9:32 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
17,079 $0 3,098,567
(Indirect)
View
2019-09-16
Other
2019-09-18
9:32 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
17,079 $0 3,098,567
(Indirect)
View
2019-09-16
Other
2019-09-18
9:32 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
8,540 $0 3,098,567
(Indirect)
View
2019-09-16
Other
2019-09-18
9:32 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
8,540 $0 3,098,567
(Indirect)
View
2019-09-16
Other
2019-09-18
9:32 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Partners III LLC
5AM Co-Investors III L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
1,002 $0 3,098,567
(Indirect)
View
2019-05-28
Conversion
2019-05-28
8:40 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
1,721,898 $0 2,844,545
(Indirect)
View
2019-05-28
Conversion
2019-05-28
8:40 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
578,447 $0 2,844,545
(Indirect)
View
2019-05-28
Conversion
2019-05-28
8:40 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
71,745 $0 2,844,545
(Indirect)
View
2019-05-28
Conversion
2019-05-28
8:40 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
24,101 $0 2,844,545
(Indirect)
View
2019-05-28
Conversion
2019-05-28
8:40 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
1,721,898 $0 2,844,545
(Indirect)
View
2019-05-28
Conversion
2019-05-28
8:40 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
578,447 $0 2,844,545
(Indirect)
View
2019-05-28
Conversion
2019-05-28
8:40 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
71,745 $0 2,844,545
(Indirect)
View
2019-05-28
Conversion
2019-05-28
8:40 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
24,101 $0 2,844,545
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
451,200 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
18,800 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
4,700 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
4,700 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
940 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
940 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
353 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
587 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
783 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
783 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
783 $0 2,656,442
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
2,862,649 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
1,338,679 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
662,864 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
73,777 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
34,500 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
17,083 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
9,303,611 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
239,776 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
4,350,709 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
112,128 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
2,154,311 $0 4,864,192
(Indirect)
View
2018-10-01
Conversion
2018-10-03
4:24 pm
N/A
N/A
ARVINAS Inc ARVN 5AM VENTURES III L.P.
5AM Co-Investors III L.P.
5AM Partners III LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
55,522 $0 4,864,192
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
2,797,635 $0 3,359,309
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
451,274 $0 3,359,309
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
116,567 $0 3,359,309
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
18,802 $0 3,359,309
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
9,204,220 $0 3,359,309
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
1,484,690 $0 3,359,309
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
383,507 $0 3,359,309
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
61,861 $0 3,359,309
(Indirect)
View
2018-06-13
Option Award
2018-06-15
9:44 pm
N/A
2028-06-12
Cidara Therapeutics Inc. CDTX ROCKLAGE SCOTT M
Director
11,000 $5.3 11,000
(Direct)
View
2018-04-02
Conversion
2018-04-04
6:41 pm
N/A
N/A
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
5,392,037 $0 6,722,076
(Indirect)
View
2018-04-02
Conversion
2018-04-04
6:41 pm
N/A
N/A
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
4,204,502 $0 6,722,076
(Indirect)
View
2018-04-02
Conversion
2018-04-04
6:41 pm
N/A
N/A
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
1,187,535 $0 6,722,076
(Indirect)
View
2017-11-21
Conversion
2017-11-21
7:16 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
1,483,107 $0 3,123,302
(Indirect)
View
2017-11-21
Conversion
2017-11-21
7:16 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
1,011,623 $0 3,123,302
(Indirect)
View
2017-11-21
Conversion
2017-11-21
7:16 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
61,795 $0 3,123,302
(Indirect)
View
2017-11-21
Conversion
2017-11-21
7:16 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
42,150 $0 3,123,302
(Indirect)
View
2017-11-21
Conversion
2017-11-21
7:16 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
10,649,003 $0 3,123,302
(Indirect)
View
2017-11-21
Conversion
2017-11-21
7:16 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
7,263,649 $0 3,123,302
(Indirect)
View
2017-11-21
Conversion
2017-11-21
7:16 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
443,708 $0 3,123,302
(Indirect)
View
2017-11-21
Conversion
2017-11-21
7:16 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
302,652 $0 3,123,302
(Indirect)
View